Quantum BioPharma (NASDAQ: QNTM) a biopharmaceutical company advancing innovative biotech assets, announced a joint clinical study with Massachusett ...

Quantum BioPharma (NASDAQ: QNTM) a biopharmaceutical company, announced the closing of its final tranche in a debenture unit offering, raising a tot ...

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”) is pleased to announce that it has closed the final tranche (“Final Tranche”) of the offering ...

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech ...

The company shed its FSD Pharma identity last year as it positions its alcohol metabolism and multiple sclerosis treatments ...

Quantum BioPharma’s CEO, Zeeshan Saeed, highlighted the company’s progress in developing products for brain disorders and alcohol health, as well as the positive clinical trial results for unbuzzd.

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“ Quantum BioPharma ” or the “ Company ”), is pleased to announce the appointment of Terry Lynch to its board of directors. Mr. Lynch ...

Quantum BioPharma (QNTM) announces the appointment of Terry Lynch to its board of directors. Lynch will be replacing Dr. Sanjiv Chopra, who has ...

Detailed price information for Quantum Biopharma Ltd Cls B Subordinate Voting S (QNTM-CN) from The Globe and Mail including charting and trades.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...